CLINICAL_TRIALS
trial_result
· 2016-11-30
Clinical Trial Update: Pradaxa Study in Non-valvular Atrial Fibrillation Patients With Severely Impaired Renal Function [Phase 4]
Summary
Phase 4 trial update of Pradaxa in patients with non-valvular atrial fibrillation and severely impaired renal function; results were posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Atrial Fibrillation | Phase 4 | Status: COMPLETED | Results posted: 2016-11-30